RECRUITING
I'm interested ...!!
Feasibility Trial Using an Inpatient Insulin Dosing Calculator
The goal of this feasibility trial is to test whether a novel insulin dosing calculator can improve blood glucose management for patients with type 2 diabetes mellitus on hospital admission. The main questions it aims to answer are: * Whether using this calculator leads to no excessive hypoglycemia? * Whether using this calculator leads to a decrease of hyperglycemia? Participants will receive initial insulin doses by the calculator on hospital admission, and the rest of care will follow standard of care. Participants will be compared with patients in the UW observational cohort who received initial insulin doses by standard of care.
Conditions:
🦠 Diabetes Mellitus, Type 2
🗓️ Study Start (Actual) 22 March 2024
🗓️ Primary Completion (Estimated) February 2025
✅ Study Completion (Estimated) February 2025
👥 Enrollment (Estimated) 85
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Seattle, Washington, United States
📍 Seattle, Washington, United States
📍 Seattle, Washington, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Patients who are admitted to University of Washington Medical Centers
    • * With history of type 2 and/or steroid-induced diabetes mellitus
    • * Receiving insulin therapy prior to admission

    Exclusion Criteria:

    • * Patients who are admitted to ICU or obstetrics ward
    • * Patients who are admitted for elective surgery or procedure
    • * Patients who present with diabetic ketone acidosis, hyperosmolar hyperglycemic state or require intravenous insulin infusion
    • * Patients who have no meal intake for 24 hours prior to admission, or planned nothing per oral (NPO) during the first 24 hours after admission
    • * Patients who report low appetite (25% or less) on admission or have a significantly decreased level of consciousness that they unlikely eat right after admission
    • * Patients who receive enteral feeding after admission
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 4 January 2024
  • First Submitted that Met QC Criteria 4 January 2024
  • First Posted 16 January 2024

Study Record Updates

  • Last Update Submitted that Met QC Criteria 9 May 2024
  • Last Update Posted 13 May 2024
  • Last Verified May 2024
I'm interested ...!!